TNFA Financial Statements

Balance sheet, income statement, cash flow, and dividends for Mymd Pharmaceuticals Inc (TNFA).


$13.17M Market Cap.

As of 04/01/2024 5:00 PM ET (MRY) • Disclaimer

TNFA Market Cap. (MRY)


TNFA Shares Outstanding (MRY)


TNFA Assets (MRY)


Total Assets

$17.86M

Total Liabilities

$5.09M

Total Investments

$3.74M

TNFA Income (MRY)


Revenue

$0

Net Income

-$4.00M

Operating Expense

$16.36M

TNFA Cash Flow (MRY)


CF Operations

-$12.98M

CF Investing

$1.85M

CF Financing

$13.07M

TNFA Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

0%

0%

-

2019

$0

0%

-

0%

-

TNFA Balance Sheet (MRY)


Metric

2023

2022

2021

2020

Total Assets

$17,862,270 (1.84%)

$17,539,980 (-29.31%)

$24,812,933 (3566.77%)

$676,697 (-93.78%)

Assets Current

$5,816,342 (7.67%)

$5,401,779 (-57.35%)

$12,665,385 (8371.72%)

$149,502 (-98.55%)

Assets Non-Current

$12,045,928 (-0.76%)

$12,138,201 (-0.08%)

$12,147,548 (2204.18%)

$527,195 (-8.17%)

Goodwill & Intangible Assets

$10,498,539 (0.00%)

$10,498,539 (0.00%)

$10,498,539 (0%)

$0 (0%)

Shareholders Equity

$12,369,572 (-15.82%)

$14,695,056 (-37.86%)

$23,647,174 (549.82%)

-$5,257,032 (-156.19%)

Property Plant & Equipment Net

$47,389 (-66.07%)

$139,662 (-6.27%)

$149,009 (-71.74%)

$527,195 (0%)

Cash & Equivalents

$2,681,010 (257.90%)

$749,090 (34.74%)

$555,967 (274.93%)

$148,284 (-71.34%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$3,742,106 (-33.02%)

$5,586,902 (-55.32%)

$12,503,071 (0%)

$0 (0%)

Investments Current

$2,242,106 (-45.14%)

$4,086,902 (-62.86%)

$11,003,071 (0%)

$0 (0%)

Investments Non-Current

$1,500,000 (0.00%)

$1,500,000 (0.00%)

$1,500,000 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$3,716,218 (39.02%)

$2,673,221 (170.95%)

$986,626 (-45.24%)

$1,801,727 (102.01%)

Accumulated Retained Earnings (Deficit)

-$101,977,067 (-8.77%)

-$93,758,904 (-19.34%)

-$78,561,568 (-61.41%)

-$48,672,523 (59.30%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$48,870 (-65.52%)

$141,721 (-4.98%)

$149,151 (-96.39%)

$4,132,002 (0%)

Debt Current

$48,870 (-25.71%)

$65,780 (23.55%)

$53,240 (-90.26%)

$546,416 (0%)

Debt Non-Current

$0 (0%)

$75,941 (-20.82%)

$95,911 (-97.33%)

$3,585,586 (0%)

Total Liabilities

$5,088,627 (78.87%)

$2,844,924 (144.04%)

$1,165,759 (-80.35%)

$5,933,729 (287.89%)

Liabilities Current

$4,988,089 (80.14%)

$2,768,983 (166.28%)

$1,039,866 (-55.72%)

$2,348,143 (53.50%)

Liabilities Non-Current

$100,538 (32.39%)

$75,941 (-39.68%)

$125,893 (-96.49%)

$3,585,586 (0%)

TNFA Income Statement (MRY)


Metric

2023

2022

2021

2020

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$5,442,886 (-1.40%)

$5,520,150 (-14.02%)

$6,420,092 (117.87%)

$2,946,703 (-13.26%)

Research & Development Expense

$7,867,795 (-13.23%)

$9,067,422 (34.43%)

$6,745,104 (173.42%)

$2,466,924 (0%)

Operating Expenses

$16,360,218 (7.05%)

$15,282,763 (-45.81%)

$28,201,247 (239.93%)

$8,296,106 (138.94%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$3,999,950 (73.68%)

-$15,197,336 (49.15%)

-$29,889,045 (-215.03%)

-$9,487,824 (-144.01%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$3,999,950 (73.68%)

-$15,197,336 (49.15%)

-$29,889,045 (-215.03%)

-$9,487,824 (-144.01%)

Preferred Dividends Income Statement Impact

$4,218,213 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$8,218,163 (45.92%)

-$15,197,336 (49.15%)

-$29,889,045 (-215.03%)

-$9,487,824 (-144.01%)

Weighted Average Shares

$1,542,453 (-96.03%)

$38,825,763 (10.88%)

$35,017,244 (24.23%)

$28,188,438 (9101.80%)

Weighted Average Shares Diluted

$1,542,453 (-96.03%)

$38,825,763 (10.88%)

$35,017,244 (24.23%)

$28,188,438 (9101.80%)

Earning Before Interest & Taxes (EBIT)

-$3,999,950 (73.68%)

-$15,197,336 (49.15%)

-$29,889,045 (-215.03%)

-$9,487,824 (-144.01%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$16,360,218 (-7.05%)

-$15,282,763 (45.81%)

-$28,201,247 (-239.93%)

-$8,296,106 (-138.94%)

TNFA Cash Flow Statement (MRY)


Metric

2023

2022

2021

2020

Net Cash Flow from Investing

$1,845,726 (-73.30%)

$6,913,163 (-65.17%)

$19,850,625 (0%)

$0 (0%)

Net Cash Flow from Financing

$13,066,819 (135.44%)

$5,550,028 (7447.67%)

$73,533 (-98.43%)

$4,677,331 (-32.85%)

Net Cash Flow from Operations

-$12,980,625 (-5.79%)

-$12,270,068 (37.13%)

-$19,516,475 (-318.49%)

-$4,663,546 (-51.70%)

Net Cash Flow / Change in Cash & Cash Equivalents

$1,931,920 (900.36%)

$193,123 (-52.63%)

$407,683 (2857.44%)

$13,785 (128.01%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$1,380,852 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$1,845,726 (-73.30%)

$6,913,163 (-62.57%)

$18,469,773 (0%)

$0 (0%)

Capital Expenditure

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

-$1,116,307 (-141.39%)

$2,697,331 (0%)

Issuance (Purchase) of Equity Shares

$0 (0%)

$5,550,028 (366.45%)

$1,189,840 (-39.91%)

$1,980,000 (-71.57%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$2,906,972 (757.71%)

$338,922 (-97.75%)

$15,036,051 (424.98%)

$2,864,145 (635.58%)

Depreciation Amortization & Accretion

$0 (0%)

$0 (0%)

$0 (0%)

$18,334 (-75.25%)

TNFA Financial Metrics (MRY)


Metric

2023

2022

2021

2020

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-63.60% (28.05%)

-88.40% (15.65%)

-104.80% (-6.83%)

-98.10% (-40.14%)

Return on Average Assets (ROAA)

-35.20% (54.17%)

-76.80% (20.91%)

-97.10% (-33.56%)

-72.70% (-34.88%)

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

-47.40% (80.93%)

-248.50% (-62.95%)

-152.50% (26.96%)

-208.80% (-170.47%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-1.46 (50.63%)

-2.95 (58.63%)

-7.13 (39.10%)

-11.71 (-2222.62%)

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

1.06 (-65.52%)

3.09 (-67.98%)

9.65 (387.60%)

-3.35 (-1984.27%)

Debt to Equity Ratio (D/E)

0.41 (111.86%)

0.19 (295.92%)

0.05 (104.34%)

-1.13 (-788.41%)

Earnings Per Share (EPS)

-5.33 (-1266.67%)

-0.39 (54.12%)

-0.85 (-150.00%)

-0.34 (97.32%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-8.42 (-2563.29%)

-0.32 (43.27%)

-0.56 (-237.58%)

-0.17 (98.35%)

Book Value Per Share (BVPS)

8.02 (2021.43%)

0.38 (-44.00%)

0.68 (462.90%)

-0.19 (-100.61%)

Tangible Assets Book Value Per Share (TABVPS)

4.77 (2537.57%)

0.18 (-55.75%)

0.41 (1604.17%)

0.02 (-99.93%)

Enterprise Value Over EBIT (EV/EBIT)

-3 (0.00%)

-3 (62.50%)

-8 (0%)

0 (0%)

Enterprise Value Over EBITDA (EV/EBITDA)

-3.24 (-8.87%)

-2.98 (60.77%)

-7.59 (-4733.12%)

-0.16 (54.09%)

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

1.17 (-40.24%)

1.95 (-83.98%)

12.18 (18931.25%)

0.06 (-99.05%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$12,980,625 (-5.79%)

-$12,270,068 (37.13%)

-$19,516,475 (-318.49%)

-$4,663,546 (-52.00%)

Enterprise Value (EV)

$12,962,842 (-71.34%)

$45,237,350 (-80.05%)

$226,787,763 (15202.90%)

$1,481,992 (13.47%)

Earnings Before Tax (EBT)

-$3,999,950 (73.68%)

-$15,197,336 (49.15%)

-$29,889,045 (-215.03%)

-$9,487,824 (-144.01%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$3,999,950 (73.68%)

-$15,197,336 (49.15%)

-$29,889,045 (-215.64%)

-$9,469,490 (-148.27%)

Invested Capital

-$256,498 (-107.00%)

$3,665,089 (-71.52%)

$12,867,712 (456.50%)

$2,312,272 (-73.84%)

Working Capital

$828,253 (-68.54%)

$2,632,796 (-77.35%)

$11,625,519 (628.76%)

-$2,198,641 (-125.04%)

Tangible Asset Value

$7,363,731 (4.58%)

$7,041,441 (-50.81%)

$14,314,394 (2015.33%)

$676,697 (-93.78%)

Market Capitalization

$13,168,015 (-70.99%)

$45,390,510 (-80.10%)

$228,097,867 (1193.72%)

$17,631,137 (956.16%)

Average Equity

$12,926,521 (-24.80%)

$17,190,647 (-39.70%)

$28,509,306 (194.66%)

$9,675,434 (74.07%)

Average Assets

$23,336,481 (17.96%)

$19,783,945 (-35.70%)

$30,767,376 (135.76%)

$13,050,262 (81.06%)

Invested Capital Average

$8,432,362 (37.89%)

$6,115,386 (-68.79%)

$19,595,261 (331.16%)

$4,544,755 (-9.82%)

Shares

1,696,690 (-95.70%)

39,470,009 (4.86%)

37,639,912 (749.67%)

4,429,934 (1598.35%)